Linking Model Realism to Clinical Relevance
Your partner in humanized drug development and precision medicine with scalable, human-relevant Microphysiological Systems (MPS)
Introducing Cell Systems
Where standardized biology meets MPS technology
Introducing Cell Systems: AngioPrime and VasQ Kit!
Reproducible, human-relevant models for predictive drug testing through the integration of standardized cell sources with AIM Biotech’s MPS technology.
AIM Biotech is leading the shift from preclinical animal models to humanized in vitro physiological models for the discovery of new medicines.
Researchers and regulators around the globe know that when it comes to predicting drug efficacy, animal models too often lead us down the wrong path. That is why they are demanding non-animal, in vitro models for drug discovery research.
AIM Biotech is answering the call with our idenTx and organiX humanized 3D microfluidic platforms. These systems combine unmatched recapitulation of human biology with unparalleled ease-of-use, resulting in a powerful solution to move medicine forward.
From our simple-to-use microfluidic platforms to our full service contract research offerings for Cancer, Immuno-oncology, Vascular Biology and Neurobiology, AIM Biotech is leading the non-animal drug discovery revolution.
Explore AIM Biotech Solutions for Humanized Drug Discovery and Functional Precision Medicine
Introducing organiX: specifically made for Organoids and Biopsies
organiX is a revolution in Human Tissue and Biopsy Culture for Functional Precision Medicine and Drug Discovery
organiX Plate - Human Tissue | Translated.
Amplify the power of organoid research and biopsy characterization with organiX
Culture – biopsies, organoids, tumor tumoroids, spheroids or any cell/tissue aggregate up to 2 mm in diameter
Contextualize – set assay conditions with perfusable vasculature, co-culture, signaling gradients and media flow for an in vivo-like tumor microenvironment (TME)
Extract – First, obtain real time high resolution imaging data and then easily extract tissue samples for downstream analysis
Level Up! – Now revolutionize your fully contextualized organoid research utilizing conventional immunohistochemistry and next generation technologies like Digital Spatial Profiling
Your study. Our lab. Human data.
Contract research services for humanized, organ-on-a-chip studies
With AIM Biotech contract research services, increasing throughput while maintaining assay sophistication is our expertise. Our pharma-focused solutions combine speed and simplicity with the ability to model complex tissues that you expect from organ-on-a-chip assays.
Let AIM Biotech accelerate your drug discovery programs using our humanized BioAvatar Technology in our state-of-the-art research services lab. Our team can even work with you to design, develop, and execute custom assays to deliver human-focused, clinically-relevant results that move your drug discovery programs forward.
Custom assay development
Rapid humanized throughput
Functional immuno-oncology assays
Answer primary research questions
Data on routine screens
In vitro organ models
Your path to predictive data and insightful diagnostics.
Products
Simple-to-use, fully scalable microfluidic systems in plate and chip formats to recapitulate human physiology.
Assays
Validated protocols in T-cell efficiency, immunotherapies, cell migration, vasculogenesis and more
Services
Custom assay development and higher-throughput, high-content screening with assays of your choice
Research
Feasibility studies
Drug/target ID
Mechanism of action
Assay development
Drug Discovery
In vitro screening
Lead optimization
ADME toxicity studies
Safety pharmacology
Diagnostics
Biomarkers
Cohort selection
Personal/targeted Tx
Clinical avatar
The secret to better blood-brain barrier models
The blood-brain barrier is notoriously difficult to model in the lab—until now. AIM’s proven technology and world-class contract research lab can get you better BBB data faster with our human-on-a-chip in vitro models.
From the expert: Roger Kamm’s insights on M-CELS
AIM Biotech co-founder Roger Kamm, PhD gives a sneak peek into his opening keynote at next week’s free workshop about M-CELS. Read on to see his personal insights as a leader in this growing field.
M-CELS – where biology and engineering meet
A free workshop this June about M-CELS will feature AIM Biotech co-founder Roger Kamm, PhD. As a keynote speaker, he’ll discuss his perspectives as a pioneering researcher at MIT.
- « Previous
- 1
- …
- 7
- 8
- 9